Humacyte Financial Overview
Humacyte's market cap is currently $245.33M. The company's EPS TTM is $-0.11; its P/E ratio is -4.94; Humacyte is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.13. See an overview of income statement, balance sheet, and cash flow financials.
